An evaluation of the monetary value of the repercussions of exposure to PM10s in terms of mortality and morbidity was carried out based on two approaches:
'willingness to pay', i.e. what individuals are theoretically prepared to pay to reduce the associated risks of mortality, morbidity and 'loss of well-being',
actual losses of economic resources represented by losses of consumption linked to premature deaths, expenditure on health care associated with morbidity and the costs of absenteeism (excluding 'loss of well-being').
The study is part of a programme involving Austria (Federal Ministry of Environment, Youth and Family Affairs), Switzerland (Federal Department of the Environment, Transport, Energy and Communications) and the WHO, with the aim of developing a common methodology for estimating the effects and costs associated with particulate (PM10) air pollution in these countries.
The study was the third part of a programme designed to quantify the monetary value of the repercussions of exposure to PM10s in terms of mortality and morbidity in France.
A summary report was written jointly by the GREQAM, the CNRS (EUREQUA), and the BETA (Strasbourg). This includes:
an estimate of excess mortality and morbidity over the short and long term,
an evaluation of the associated costs.